Expensive immunotherapy shows no advantage over placebo for recurrent miscarriage patients
Wednesday, August 25, 2010 - 17:56
in Health & Medicine
(PhysOrg.com) -- The University of Chicago Recurrent Pregnancy Loss Program (RPL) recently completed a comprehensive study examining the use of immunotherapy to help couples that had experienced recurrent miscarriages for unexplained reasons achieve a successful pregnancy.